loadpatents
name:-0.026515960693359
name:-0.0079629421234131
name:-0.018839120864868
BioLineRx Ltd. Patent Filings

BioLineRx Ltd.

Patent Applications and Registrations

Patent applications and USPTO patent grants for BioLineRx Ltd..The latest application filed is for "cxcr4 inhibitor for the treatment of acute respiratory distress syndrome and viral infections".

Company Profile
27.7.45
  • BioLineRx Ltd. - ModiIn IL
  • BioLineRx Ltd. - Modiln IL
  • BioLineRx Ltd. - MoiIn IL
  • BIOLINERX LTD. - Jerusalem IL
  • BioLineRX Ltd - Jerusalem IL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Cxcr4 Inhibitor For The Treatment Of Acute Respiratory Distress Syndrome And Viral Infections
App 20220288155 - STEIN; Gideon
2022-09-15
Specific Combination Therapy For Treatment Of Pancreatic Cancer
App 20220072087 - STEIN; Gideon ;   et al.
2022-03-10
Treatment Of Metastatic Pancreatic Adenocarcinoma
App 20220010016 - VAINSTEIN-HARAS; Abi ;   et al.
2022-01-13
Methods Of Selecting Treatment For Cxcr4-associated Cancer
App 20210338767 - BOHANA-KASHTAN; Osnat ;   et al.
2021-11-04
Methods of treating acute myeloid leukemia
Grant 10,993,985 - Pereg , et al. May 4, 2
2021-05-04
Agi-134 Combined With A Checkpoint Inhibitor For The Treatment Of Solid Tumors
App 20210121491 - LEVY; Irit Carmi
2021-04-29
Compositions, Articles Of Manufacture And Methods For Treating Cancer
App 20200390855 - PELED; Amnon ;   et al.
2020-12-17
Compositions, articles of manufacture and methods for treating cancer
Grant 10,786,547 - Peled , et al. September 29, 2
2020-09-29
Compositions And Methods For Treating Cancer
App 20200297803 - PELED; Amnon ;   et al.
2020-09-24
Compositions And Methods For Treating Cancer
App 20200297802 - PELED; Amnon ;   et al.
2020-09-24
Compositions And Methods For Treating Cancer
App 20200297804 - PELED; Amnon ;   et al.
2020-09-24
Compositions And Methods For Treating Cancer
App 20200297805 - PELED; Amnon ;   et al.
2020-09-24
Compositions And Methods For Treating Cancer
App 20200297809 - PELED; Amnon ;   et al.
2020-09-24
Compositions And Methods For Treating Cancer
App 20200297810 - PELED; Amnon ;   et al.
2020-09-24
Compositions And Methods For Treating Cancer
App 20200297811 - PELED; Amnon ;   et al.
2020-09-24
Compositions And Methods For Treating Cancer
App 20200297812 - PELED; Amnon ;   et al.
2020-09-24
Compositions And Methods For Treating Cancer
App 20200297808 - PELED; Amnon ;   et al.
2020-09-24
Compositions And Methods For Treating Cancer
App 20200297807 - PELED; Amnon ;   et al.
2020-09-24
Compositions And Methods For Treating Cancer
App 20200297806 - PELED; Amnon ;   et al.
2020-09-24
Methods Of Treating Diseases Associated With Vascular Smooth Muscle Cell Proliferation
App 20200282009 - PELED; Amnon
2020-09-10
Compositions And Methods For Treating Cancer
App 20200276267 - PELED; Amnon ;   et al.
2020-09-03
Compositions And Methods For Treating Cancer
App 20200268840 - PELED; Amnon ;   et al.
2020-08-27
Compositions And Methods For Treating Cancer
App 20200268841 - PELED; Amnon ;   et al.
2020-08-27
Compositions And Methods For Treating Cancer
App 20200268846 - PELED; Amnon ;   et al.
2020-08-27
Compositions And Methods For Treating Cancer
App 20200268845 - PELED; Amnon ;   et al.
2020-08-27
Compositions And Methods For Treating Cancer
App 20200268843 - PELED; Amnon ;   et al.
2020-08-27
Compositions And Methods For Treating Cancer
App 20200268844 - PELED; Amnon ;   et al.
2020-08-27
Compositions And Methods For Treating Cancer
App 20200268842 - PELED; Amnon ;   et al.
2020-08-27
Compositions and methods for treating cancer
Grant 10,682,390 - Peled , et al.
2020-06-16
Methods Of Treating Acute Myeloid Leukemia
App 20190046602 - PEREG; Yaron ;   et al.
2019-02-14
Methods Of Treating Acute Myeloid Leukemia With A Flt3 Mutation
App 20190038703 - PELED; Amnon ;   et al.
2019-02-07
Methods Of Treating Myeloid Leukemia
App 20180344801 - PELED; Amnon ;   et al.
2018-12-06
Methods Of Treating Myeloid Leukemia
App 20180311308 - PELED; Amnon ;   et al.
2018-11-01
Cxcr4 Binding Agents For Treatment Of Diseases
App 20180221393 - PELED; Amnon ;   et al.
2018-08-09
Methods Of Obtaining Mononuclear Blood Cells And Uses Thereof
App 20180161366 - PELED; Amnon ;   et al.
2018-06-14
Compositions, Articles Of Manufacture And Methods For Treating Cancer
App 20180140670 - PELED; Amnon ;   et al.
2018-05-24
Compositions And Methods For Treating Cancer
App 20180140660 - PELED; Amnon ;   et al.
2018-05-24
Methods Of Mesenchymal Stem Cell Mobilization And Expansion
App 20180142211 - PELED; Amnon ;   et al.
2018-05-24
Methods Of Treating Acute Myeloid Leukemia With A Flt3 Mutation
App 20160243187 - PELED; Amnon ;   et al.
2016-08-25
Methods Of Treating Myeloid Leukemia
App 20160082071 - PELED; Amnon ;   et al.
2016-03-24
Crystalline Forms Of The Tri-mesylate Salt Of Perphenazine-gaba And Process Of Producing The Same
App 20130150352 - NUDELMAN; Abraham ;   et al.
2013-06-13
Crystalline forms of the tri-mesylate salt of perphenazine-GABA and process of producing the same
Grant 8,377,929 - Nudelman , et al. February 19, 2
2013-02-19
Conjugates comprising a GABA- or glycine compound, pharmaceutical compositions and combinations thereof and their use in treating CNS disorders
Grant 8,222,296 - Nudelman , et al. July 17, 2
2012-07-17
Method Of Promoting Muscle Tissue Repair
App 20100216739 - Lifshitz; Ran ;   et al.
2010-08-26
Company Registrations
NCAGE Code3002ABIOLINERX LTD
NCAGE CodeSPV18BIOLINERX LTD
CAGE CodeSPV18BIOLINERX LTD NEW PROJECT LTD - FORMERLY
CAGE Code3002ABIOLINERX LTD BIOLINE THERAPEUTICS LTD - FORMERLY
S.A.M. Registration3002A [533746764]BIOLINERX LTD BIOLINE THERAPEUTICS LTD - FORMERLY
SEC0001498403BioLineRx Ltd. of ISRAEL
SEC0001704335BioLineRx Ltd./ADR

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed